Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Vinodh Doss

Vascular Neurology Richmond, VA Doctor of Osteopathy

NPI 1336348085 CMS profile 196288

5801 Bremo Rd, Richmond, VA 23226

Open in the dashboard

General payments

$5,410

83 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Vinodh Doss of Richmond, VA is reported in the CMS Open Payments database as having received $5,410 across 83 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 75th percentile of Vascular Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $541 8
2024 General $419 8
2023 General $284 10
2022 General $1,088 21
2021 General $199 4
2020 General $584 7
2019 General $2,296 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Vinodh Doss
  • Vascular Neurology median
  • Middle half of Vascular Neurology
  • National median

In program year 2025, general payments to Vinodh Doss were reported at $541. Among 416 Vascular Neurology profiles paid that year, the median was $360 and the middle half received between $91 and $1,472.

Show as a table
Year Vinodh Doss Vascular Neurology median Middle half National median
2019 $2,296 $263 $102–$1,640 $163
2020 $584 $153 $45–$1,000 $114
2021 $199 $261 $100–$1,355 $132
2022 $1,088 $242 $87–$1,273 $149
2023 $284 $322 $97–$1,266 $160
2024 $419 $247 $70–$1,053 $164
2025 $541 $360 $91–$1,472 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. MicroVention, Inc. $2,081 19 payments
  2. Balt USA, LLC $800 8 payments
  3. Imperative Care, INc $724 12 payments
  4. Medtronic, Inc. $622 10 payments
  5. Penumbra, Inc. $330 10 payments
  6. Asahi Intecc USA, Inc. $304 5 payments
  7. Medtronic USA, Inc. $156 5 payments
  8. Stryker Corporation $109 5 payments
  9. Portola Pharmaceuticals, Inc. $73 1 payment
  10. Route 92 Medical, Inc. $63 2 payments
  11. Other $148 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,554 75 payments
  2. Travel and Lodging $1,856 8 payments
Products named General payments · program years 2019–2025
  1. WEB $1,761 14 payments
  2. ZOOM 88-T LARGE DISTAL PLATFORM $724 12 payments
  3. Optima Thermal Coil System $688 5 payments
  4. ZOOM REPERFUSION CATHETER $476 9 payments
  5. Pipeline $345 6 payments
  6. WEB ANEURYSM EMBOLIZATION SYSTEM $264 3 payments
  7. PERIPHERAL VASCULAR $219 2 payments
  8. Penumbra System $213 7 payments
  9. MO.MA ULTRA $212 1 payment
  10. Solitaire $143 4 payments
  11. Other $859 28 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

53

Median for Neurology: 833

Drug cost

$657

Median for Neurology: $202,670

Branded share of claims

77.4%

Median for Neurology: 25.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 41 $332
Cilostazol Generic 12 $324

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,695 Part D prescribers listed as Neurology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 34 billing codes

Paid by Medicare

$46,120

Medicare's payments for the services billed

Medicare patients

128

Average age 77

Services billed

278

73 women, 55 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 59%
Ischemic heart disease 45%
Diabetes 40%
Chronic kidney disease 34%
Atrial fibrillation 31%
Depression 29%
COPD 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

83 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Neurology in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record